Kinnate Biopharma Inc. Human Resources Contracts & Agreements
15 Contracts & Agreements
- Bonus & Incentive Agreements (3 contracts)
- Change of Control Agreements (5)
- Compensation Agreements (2)
- Employment Agreements (5)
- Amended and Restated Outside Director Compensation Policy (Filed With SEC on March 15, 2023)
- Change in Control and Severance Agreement between the Company and Neha Krishnamohan (Filed With SEC on June 7, 2021)
- Employment Letter between the Company and Neha Krishnamohan (Filed With SEC on June 7, 2021)
- Outside Director Compensation Policy (Filed With SEC on November 30, 2020)
- 2020 Equity Incentive Plan and forms of agreements thereunder, to be in effect upon the completion of this offering (Filed With SEC on November 30, 2020)
- Change in Control and Severance Agreement between the Registrant and Richard Williams, MBBS, Ph.D (Filed With SEC on November 13, 2020)
- Change in Control and Severance Agreement between the Registrant and Eric Murphy, Ph.D (Filed With SEC on November 13, 2020)
- Change in Control and Severance Agreement between the Registrant and Mark Meltz (Filed With SEC on November 13, 2020)
- Change in Control and Severance Agreement between the Registrant and Nima Farzan (Filed With SEC on November 13, 2020)
- Executive Incentive Compensation Plan (Filed With SEC on November 13, 2020)
- Employment Letter between the Registrant and Richard Williams, MBBS, Ph.D (Filed With SEC on November 13, 2020)
- Employment Letter between the Registrant and Eric Murphy, Ph.D (Filed With SEC on November 13, 2020)
- Employment Letter between the Registrant and Mark Meltz (Filed With SEC on November 13, 2020)
- Employment Letter between the Registrant and Nima Farzan (Filed With SEC on November 13, 2020)
- 2018 Equity Incentive Plan, as amended, and forms of agreement thereunder (Filed With SEC on November 13, 2020)
